6505--Mometasone Nasal Spray

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79722R0028 for an unrestrictive procurement for Mometasone Furoate Nasal Spray for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation 36E79722R0028 will be electronically issued in commercial product format in accordance with FAR Part 12 on or about July 8, 2022, with a tentative closing date of July 22, 2022. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to: deborah.fassl@va.gov.

The estimated annual requirements are as follows:

ITEM

DESCRIPTION

PACKAGE

SIZE

(BT)

TOTAL

ESTIMATED

ANNUAL

USAGE

(BT)

1

MOMETASONE FUROATE MONOHYDRATE 50MCG/ACTUATION; SUSP, NASAL,17GM

1

61,887